Micronutrients in Oncological Intervention

Area of Science:

• Oncology
• Nutritional Science
• Pharmacology

Background:

• Many cancer patients use nutritional supplements, believing they offer anticancer and antitoxicity benefits.
• Prevalence of supplement use ranges from 30%-90%, often without physician awareness.
• Commonly used micronutrients include selenium, vitamin C, and vitamin D.

Purpose of the Study:

• To investigate the complex relationship between nutritional supplements and cancer treatment efficacy and tolerance.
• To address oncological concerns regarding potential interference of supplements with chemotherapy and radiotherapy.
• To explore the potential benefits of individualized nutritional supplementation in cancer care.

Main Methods:

• Review of recent studies examining the effects of micronutrient supplementation in cancer patients.
• Analysis of evidence regarding supplement impact on treatment tolerance, compliance, and discontinuation rates.
• Consideration of factors influencing supplement efficacy, including diet, genetics, tumor type, and treatment regimen.

Main Results:

• Growing evidence suggests that certain micronutrients, such as selenium, can improve treatment tolerance.
• Appropriate supplementation may lead to increased patient compliance and reduced treatment discontinuations.
• Individualized nutritional strategies may benefit specific patient subsets.

Conclusions:

• Nutritional supplements can have a dual role in cancer care, with potential benefits and risks.
• Open communication between clinicians and patients regarding supplement use is crucial.
• Individualized, physician-guided supplementation advice is recommended for optimal patient outcomes.